Literature DB >> 24684514

Should all patients be optimized to the same preoperative hemoglobin level to avoid transfusion in primary knee arthroplasty?

M Basora1, M Tió, N Martin, L Lozano, F Salazar, G Sánchez-Etayo, B Raquel, A Pereira.   

Abstract

BACKGROUND AND
OBJECTIVE: Optimization of the preoperative hemoglobin (Hb) level is an effective way to reduce allogeneic transfusion in total knee arthroplasty (TKA) though the procedure is expensive, requires close monitoring and is often inconvenient for patients with reduced mobility. Our aim was to investigate the value of preoperative Hb levels to predict transfusion and thereby tailoring Hb optimization to patient characteristics.
MATERIALS AND METHODS: All consecutive patients who undergone primary TKA in our center over 2 years, and received tranexamic acid intraoperatively, were reviewed. The adjusted association between preoperative Hb levels and transfusion was assessed by multivariate logistic regression, and the estimated probability of transfusion for individual patients was derived from the logistic model.
RESULTS: Out of the 784 patients who meet the inclusion criteria, risk of transfusion was associated with poorer performance status, as measured by the America Association of Anestesiology (ASA) score III/IV (OR: 3·3, P < 0·001) and lower preoperative Hb level (OR 3·8 for each g/dl below 13 g/dl; P < 0·001). According to the Hb level, the estimated probability of transfusion was 0·03 (range: 0·03-0·64) for ASA I/II patients and 0·10 (range: 0·10-0·84) for ASA III/IV.
CONCLUSION: Not all the patients undergoing TKA who receive tranexamic acid need the same preoperative Hb optimization target. Two easily available factors, such as the ASA score and the Hb level, can help individualize the Hb optimization target.
© 2014 International Society of Blood Transfusion.

Entities:  

Keywords:  arthroplasty; erythrocyte transfusion; hemoglobin; knee replacement; tranexamic acid

Mesh:

Substances:

Year:  2014        PMID: 24684514     DOI: 10.1111/vox.12147

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

Review 1.  Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain.

Authors:  Elvira Bisbe; Misericordia Basora; María J Colomina
Journal:  Blood Transfus       Date:  2017-01-26       Impact factor: 3.443

2.  Preoperative haemoglobin cut-off values for the prediction of post-operative transfusion in total knee arthroplasty.

Authors:  Jared Ze Yang Yeh; Jerry Yongqiang Chen; Hamid Rahmatullah Bin Abd Razak; Bryan Huai Gu Loh; Ying Hao; Andy Khye Soon Yew; Shi-Lu Chia; Ngai Nung Lo; Seng Jin Yeo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-05-28       Impact factor: 4.342

3.  Cost-effectiveness analysis of ferric carboxymaltose in pre-operative haemoglobin optimisation in patients undergoing primary knee arthroplasty.

Authors:  Misericordia Basora; Arturo Pereira; Miquel Coca; Montse Tió; Lluís Lozano
Journal:  Blood Transfus       Date:  2018-06-26       Impact factor: 3.443

4.  Perioperative blood transfusions in hip and knee arthroplasty: a retrospective assessment of combined risk factors.

Authors:  Hans-Christoph Erben; Florian Hess; JoEllen Welter; Nicole Graf; Marc P Steurer; Thomas A Neff; Ralph Zettl; Alexander Dullenkopf
Journal:  Arch Orthop Trauma Surg       Date:  2021-02-19       Impact factor: 2.928

5.  Impact of body mass index on hemoglobin level and blood transfusion in total knee arthroplasty: A retrospective case control study.

Authors:  Khaldoon Bashaireh; Osama Aljararhih; Khaldoon Alawneh
Journal:  Ann Med Surg (Lond)       Date:  2020-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.